Literature DB >> 2558158

The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification.

K H Chang1, P Auvinen, T Hyypiä, G Stanway.   

Abstract

The complete nucleotide sequence of the genome of coxsackievirus A9 (CAV-9) has been determined from cDNA cloned in Escherichia coli. Excluding the 3' poly(A) stretch, the RNA genome is 7452 nucleotides long and encodes a single polyprotein of 2201 amino acids. Comparison of the nucleotide and predicted amino acid sequences with those of the coxsackieviruses B1, B3 and B4 reveals a surprising degree of homology, with overall amino acid homologies of 86.9%, 86.2% and 87.0%, respectively. In contrast, there is much less homology to another coxsackie A virus, CAV-21, 60.4% overall amino acid homology. This demonstrates the high degree of diversity within the CAV group and indicates that the current classification does not directly correlate with molecular genetic properties. One major feature of CAV-9 is an insertion, relative to all other enteroviruses sequenced to date, which is located at the C terminus of VP1, and includes an arginine-glycine-aspartic acid tripeptide. Such sequences in a number of other proteins are known to have activity in promoting attachment to cell receptors and the implications for CAV-9 receptor binding are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558158     DOI: 10.1099/0022-1317-70-12-3269

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  64 in total

1.  Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry.

Authors:  Y Boonyakiat; P J Hughes; F Ghazi; G Stanway
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections.

Authors:  G J Zoll; W J Melchers; H Kopecka; G Jambroes; H J van der Poel; J M Galama
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

Review 3.  Picornavirus uncoating.

Authors:  M S Smyth; J H Martin
Journal:  Mol Pathol       Date:  2002-08

4.  Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures.

Authors:  E V Pilipenko; S V Maslova; A N Sinyakov; V I Agol
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

Review 5.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  The 3' terminal sequence of a human astrovirus.

Authors:  M M Willcocks; M J Carter
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Recombination in circulating enteroviruses.

Authors:  Alexander N Lukashev; Vasilii A Lashkevich; Olga E Ivanova; Galina A Koroleva; Ari E Hinkkanen; Jorma Ilonen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Simultaneous detection and differentiation of human rhino- and enteroviruses in clinical specimens by real-time PCR with locked nucleic Acid probes.

Authors:  Riikka Osterback; Tuire Tevaluoto; Tiina Ylinen; Ville Peltola; Petri Susi; Timo Hyypiä; Matti Waris
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

9.  Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group.

Authors:  G Stanway; N Kalkkinen; M Roivainen; F Ghazi; M Khan; M Smyth; O Meurman; T Hyypiä
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Internalization of coxsackievirus A9 is mediated by {beta}2-microglobulin, dynamin, and Arf6 but not by caveolin-1 or clathrin.

Authors:  Outi Heikkilä; Petri Susi; Tuire Tevaluoto; Heidi Härmä; Varpu Marjomäki; Timo Hyypiä; Saija Kiljunen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.